SAVING LIVES ADVANCING SCIENCE THROUGH CLINICAL RESEARCH

1
SAVING LIVES ADVANCING SCIENCE THROUGH CLINICAL
RESEARCH
2
Vision and Mission
The Vision of the Coalition of National Cancer
Cooperative Groups is to improve the survival and
quality of life of cancer patients as the
national leader in increasing participation in
clinical trials.
3
Our strategic imperatives address the root causes
of low clinical trial participation
Manifesting leadership
4
Through its Programmatic Plan, the Coalition adds
significant value to its constituents health
care professionals patients Cooperative Group
members and, Industry
5
Manifesting Leadership Build Alliances

• Summit Series CLC, CRPF (formerly CRFA), ONS
  ASCO
• National Coalition for Cancer Research
• Intercultural Cancer Council
• National Dialogue on Cancer

6
Patients

• Patient Advisory Board
• PAB/NCI Director Consumer Liaison Group
• 36 Advocate Groups Associate members
• Cancer Leadership Council

7
Other Major Affiliates

• Pharma 13 companies sponsorship
• ACS Awareness Campaign/TrialCheck
• NCI PAB/DCLG
• TrialCheck
• ASCO TrialCheck Peoplelivingwithcancer.org
  Recognition Awards

8
National Awareness Campaign
9
What We Achieved in 2002

• Nearly 208 million media impressions delivered
• 239 PBS stations nationwide aired Test of Hope
• 90 of US households covered
• 20 of top 25 media markets 40 million people
• 5 million people saw Nightline
• 87 recall rate for Newsweek section
• May online traffic spiked to 20,000

10
Campaign Results Continued

• CancerTrialsHelp.org, patient education materials
  to local PBS stations
• 500 Test of Hope 30-minute tapes
• 4 live online discussions drew over 16,000
  participants
• CTH.org re-launch in August new home for
  content
• October Capitol Hill event with Lance Armstrong

11
2002 Highlights

• patient testimonials from Patrons Benefactors
  in Newsweek
• Stories featured online
• All donors credited
• URL/800 s listed

12
One-Hour PBS Special

• Remains active in PBS library for 1 year
• Patron Benefactor spots at beginning end
• All donors credited
• Involvement of Cokie Roberts raised show profile

13
CancerTrialsHelp.org

• Member Advocate site links to CTH
• Forging strong partnership with People Living
  with Cancer
• Listed in other sites including Cancer.com and
  the American Cancer Society

14
Patient Stories in Banner Ads
15
2003 Campaign Schedule

• 154 Million Total Planned Impressions
• Newsweek 8-page Special Section
• 5 Single Pages Provided by Newsweek
  (4 Health Sections June
  Mens Health)
• 6 Online Viewpoint Discussions
• Sustained Online Campaign
• Continued Cross Promotions

16
2003 Plans Continued

• Member Outreach professionals advocates
• Broad reprint distribution 300k goal
• Pharmacy counters
• Fortune 500 CEOs and Corporate Medical Directors
• Via broad-based membership organizations such as
  SHRM, AARP, SHA, others
• Impact Measurement Print Online

17
TrialCheck
18
TrialCheckSM
19
TrialCheck Key Differentiators

• Screening process
• Patient-specific screening process
• 5 to 8 easy questions allow healthcare
  professionals to quickly identify appropriate
  trial(s)
• Meaningful results in less than 90 seconds
• Data quality
• Current and timely data due to continual updates
  from Cooperative Groups
• Only clinical trials search engine that links
  protocols to IRB-approved sites

20
TrialCheck Key Differentiators (cont.)

• Easy to tailor
• TrialCheck Coordinator program
• Institutions can easily and quickly add their
  trials
• Patient advocate version can direct trial
  candidates to sites within preferred zip code
• Flexibility
• Pharmaceutical companies can add their trials
• TrialCheck users can search for these trials with
  same powerful and unbiased filter used for
  Cooperative Group trials

21
TrialCheck Evolution

• Launched TrialCheck during Oct/Nov 2001
• Registered users total 4,200 (original target
  2,000 by year end 2002)
• Searches have resulted in 140K trial
  identifications

22
TrialCheck Clinical Version

• Enhance search functionality
• Search by drug
• Improve site identifiers
• TrialCheck Coordinator Program
• Continue to add Industry trials
• Develop Enrollment Tracker
• Launch PDA

23
TrialCheck PDA Version
24
TrialCheck Patient Advocacy

• Successfully completed pilot in Breast Cancer
  with Y-ME and the Patient Advocate Foundation
• Thoracic, GI, GU, Liquid tumor disease language
  under review by patient advocate organizations
  implementation planned for IIQ 2003
• Other diseases to be ready by end of IIQ 2003

25
Patient Advocacy
26
Patient Advocacy Purpose and Structure

• Purpose to further progress in cancer research
  and improve outcomes by increasing patient
  involvement and participation in clinical trial
• Nine-member Patient Advisory Board
• Provides direction to the Patient Advocate
  Program
• Composed of lead advocate in each Cooperative
  Group

27
Patient Advocacy 2002 Selected Accomplishments
28
2002 Selected Accomplishments (cont.)
Accomplishments
Identified Needs

• Cooperative Group Community feedback on NCI pilot
  programs
• Ensure patient perspective in Coalition programs

• Published report of interviews conducted by
  DCLG/PAB on NCI pilot programs
• Provided input and consultation for Coalition
  programs and communications

29
Patient Advocacy 2003 Goals

• Continue improving advocate effectiveness and
  impact through
• Better tools
• Advocate Training Program
• Patient Advocate Version of TrialCheck and
  cancertrialshelp.org)
• More awareness (e.g., Newsweek, Advocate
  Partnerships brochure)
• Create best-practice models for patient advocates

30
Patient Advocacy 2003 Goals (cont.)

• ECOG/Y-ME
• PanCan/CTIP/TrialCheck PALS Program
• Small grant program to seed proof-of-concept
• Implement NCI Report recommendation

31
Mission Double participation in cancer
clinical trials
A Virtuous Cycle
32
SAVING LIVES ADVANCING SCIENCE THROUGH CLINICAL
RESEARCH